These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23739201)

  • 1. Timing of surgery after long-course neoadjuvant chemoradiotherapy for rectal cancer: a systematic review of the literature.
    Foster JD; Jones EL; Falk S; Cooper EJ; Francis NK
    Dis Colon Rectum; 2013 Jul; 56(7):921-30. PubMed ID: 23739201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing the Interval Between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer: A Meta-analysis of Published Studies.
    Petrelli F; Sgroi G; Sarti E; Barni S
    Ann Surg; 2016 Mar; 263(3):458-64. PubMed ID: 24263329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review and network meta-analysis of randomised controlled trials comparing neoadjuvant treatment strategies for stage II and III rectal cancer.
    Simillis C; Khatri A; Dai N; Afxentiou T; Jephcott C; Smith S; Jadon R; Papamichael D; Khan J; Powar MP; Fearnhead NS; Wheeler J; Davies J
    Crit Rev Oncol Hematol; 2023 Mar; 183():103927. PubMed ID: 36706968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical Outcomes in Total Neoadjuvant Therapy for Rectal Cancer Versus Standard Long-course Chemoradiation: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Lin W; Li C; Clement EA; Brown CJ; Raval MJ; Karimuddin AA; Ghuman A; Phang PT
    Ann Surg; 2024 Apr; 279(4):620-630. PubMed ID: 38009646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged interval to surgery following neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A meta-analysis of randomized controlled trials.
    Owens PW; Saeed M; McCawley N; Loughlin P; Kearney DE; Burke JP; McNamara DA; Sahebally SM
    Surgeon; 2024 Jun; 22(3):166-173. PubMed ID: 38521683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal Interval to Surgery After Neoadjuvant Chemoradiotherapy in Rectal Cancer: A Systematic Review and Meta-analysis.
    Du D; Su Z; Wang D; Liu W; Wei Z
    Clin Colorectal Cancer; 2018 Mar; 17(1):13-24. PubMed ID: 29153429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does a long interval between neoadjuvant chemoradiotherapy and surgery benefit the clinical outcomes of locally advanced rectal cancer? A systematic review and meta analyses.
    Yu M; Wang DC; Li S; Huang LY; Wei J
    Int J Colorectal Dis; 2022 Apr; 37(4):855-868. PubMed ID: 35279746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving role of neoadjuvant therapy in rectal cancer.
    Schrag D
    Curr Treat Options Oncol; 2013 Sep; 14(3):350-64. PubMed ID: 23828092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemoradiotherapy with capecitabine followed by laparoscopic resection in locally advanced tumors of middle and low rectum - toxicity and complications of the treatment.
    Soumarova R; Skrovina M; Bartos J; Gruna J; Wendrinski A; Czudek S; Kycina R; Parvez J
    Eur J Surg Oncol; 2010 Mar; 36(3):251-6. PubMed ID: 19879716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing to achieve the best recurrence-free survival after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: experience in a large-volume center in China.
    Wang X; Zheng Z; Zhu H; Yu Q; Huang S; Lu X; Huang Y; Chi P
    Int J Colorectal Dis; 2021 May; 36(5):1007-1016. PubMed ID: 33398511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standard (8 weeks) vs long (12 weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR).
    Monsellato I; Alongi F; Bertocchi E; Gori S; Ruffo G; Cassinotti E; Baldari L; Boni L; Pernazza G; Pulighe F; De Nisco C; Perinotti R; Morpurgo E; Contardo T; Mammano E; Elmore U; Delpini R; Rosati R; Perna F; Coratti A; Menegatti B; Gentilli S; Baroffio P; Buccianti P; Balestri R; Ceccarelli C; Torri V; Cavaliere D; Solaini L; Ercolani G; Traverso E; Fusco V; Rossi M; Priora F; Numico G; Franzone P; Orecchia S
    BMC Cancer; 2019 Dec; 19(1):1215. PubMed ID: 31842784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients.
    Mei SW; Liu Z; Wei FZ; Chen JN; Wang ZJ; Shen HY; Li J; Zhao FQ; Pei W; Wang Z; Wang XS; Liu Q
    World J Gastroenterol; 2020 Aug; 26(31):4624-4638. PubMed ID: 32884221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical, oncological, and functional outcomes of local and radical resection after neoadjuvant chemotherapy or chemoradiotherapy for early- and mid-stage rectal cancer: a systematic review and meta-analysis.
    Tan S; Ou Y; Huang S; Gao Q
    Int J Colorectal Dis; 2023 May; 38(1):132. PubMed ID: 37193915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of the effect of extending the interval after long-course chemoradiotherapy before surgery in locally advanced rectal cancer.
    Ryan ÉJ; O'Sullivan DP; Kelly ME; Syed AZ; Neary PC; O'Connell PR; Kavanagh DO; Winter DC; O'Riordan JM
    Br J Surg; 2019 Sep; 106(10):1298-1310. PubMed ID: 31216064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Systematic Review of Local Excision After Neoadjuvant Therapy for Rectal Cancer: Are ypT0 Tumors the Limit?
    Hallam S; Messenger DE; Thomas MG
    Dis Colon Rectum; 2016 Oct; 59(10):984-97. PubMed ID: 27602930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonoperative Management Versus Radical Surgery of Rectal Cancer After Neoadjuvant Therapy-Induced Clinical Complete Response: A Markov Decision Analysis.
    de Buck van Overstraeten A; Khorasani S; Kennedy E; Look Hong NJ
    Dis Colon Rectum; 2020 Aug; 63(8):1080-1089. PubMed ID: 32398412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review.
    Ryan JE; Warrier SK; Lynch AC; Heriot AG
    Colorectal Dis; 2015 Oct; 17(10):849-61. PubMed ID: 26260213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival Benefit for Metformin Through Better Tumor Response by Neoadjuvant Concurrent Chemoradiotherapy in Rectal Cancer.
    Kim JM; Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
    Dis Colon Rectum; 2020 Jun; 63(6):758-768. PubMed ID: 32384406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.